Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol in non-traumatic subarachnoid hemorrhage
NCT06569212Phase 4Active, not recruiting
- Start
- Sep 2024
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metoprolol in subarachnoid hemorrhage (SAH). Started Sep 2024; status: active, not recruiting.
02
Drugs
metoprolol
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT06569212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06569212.